Rheumatology 2003; 42: 797-798
© 2003 British Society for Rheumatology
Letters to the Editor |
Cryofibrinogenaemia complicated by amyloidosis: a new association
Centre for Rheumatic Diseases, University Department of Medicine, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER and
1 Biochemistry Department, Wishaw General Hospital, 50 Netherton Street, Wishaw ML2 0DP, UK
| The first 10% of the full text of this article appears below. |
SIR, Cryofibrinogen was first described in 1955 by Korst and Kratochvil [1]. It refers to a plasma complex of fibrin, fibrinogen and fibronectin that precipitates in plasma cooled to 4°C and may dissolve upon warming to 37°C. Cryofibrinogenaemia may occur as a primary event or secondarily to a wide range of diseases, including carcinoma, acute and chronic inflammatory processes, collagen vascular diseases and thromboembolic disorders, but the aetiology of this condition remains obscure.
We report a patient with cryofibrinogenaemia who initially responded to stanozolol and then developed significant